Zura Bio Ltd — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Zura Bio Ltd filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Net Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($18.04M) | Nov 13, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($15.99M) | Aug 14, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($17.44M) | May 8, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($20.70M) | Nov 13, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($10.33M) | Aug 14, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($7.75M) | May 8, 2025 |
| Q3 | 2024 | Sep 30, 2023 | ($8.27M) | Nov 7, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($34.03M) | Aug 13, 2024 |
| Q1 | 2024 | Mar 31, 2023 | ($9.59M) | May 9, 2024 |
| Q2 | 2023 | Dec 31, 2022 | ($8.70M) | Aug 14, 2023 |
| Q3 | 2023 | Sep 30, 2022 | ($1.10M) | Nov 13, 2023 |
| Q3 | 2022 | Jun 30, 2022 | $2.27M | Nov 14, 2022 |
| Q2 | 2023 | Jun 30, 2022 | ($925.0K) | Aug 14, 2023 |
| Q3 | 2022 | Mar 31, 2022 | $147.9K | Nov 14, 2022 |
| Q1 | 2023 | Mar 31, 2022 | ($7.82M) | May 12, 2023 |
| Q2 | 2022 | Mar 31, 2022 | $147.9K | Aug 12, 2022 |
| Q3 | 2022 | Sep 30, 2021 | $5.79M | Nov 14, 2022 |
| Q3 | 2022 | Jun 30, 2021 | ($19.1K) | Nov 14, 2022 |
| Q2 | 2022 | Jun 30, 2021 | ($19.1K) | Aug 12, 2022 |
| Q1 | 2022 | Mar 31, 2021 | ($33.0K) | May 13, 2022 |
Operating Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($19.52M) | Nov 13, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($18.06M) | Aug 14, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($19.25M) | May 8, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($19.32M) | Nov 13, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($11.76M) | Aug 14, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($8.38M) | May 8, 2025 |
| Q3 | 2024 | Sep 30, 2023 | ($10.19M) | Nov 7, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($33.91M) | Aug 13, 2024 |
| Q1 | 2024 | Mar 31, 2023 | ($7.72M) | May 9, 2024 |
| Q3 | 2023 | Sep 30, 2022 | ($1.07M) | Nov 13, 2023 |
| Q2 | 2023 | Jun 30, 2022 | ($927.0K) | Aug 14, 2023 |
| Q1 | 2023 | Mar 31, 2022 | ($7.82M) | May 12, 2023 |
| Q3 | 2022 | Sep 30, 2021 | ($321.9K) | Nov 14, 2022 |
| Q2 | 2022 | Jun 30, 2021 | ($19.1K) | Aug 12, 2022 |
| Q1 | 2022 | Mar 31, 2021 | ($33.0K) | May 13, 2022 |